|
Single Site Evaluation of Quality of Life of Patients Receiving Trimetrexate, 5-Fluorouracil, and Leucovorin, - NFL - for Previously Treated and Untreated Metastatic Colorectal Cancer. |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
Julianah Bee Abdul Latiff |
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - Guerbet; QuintilesIMS; Sirtex Medical |
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; MSD; Oncosil; Sirtex Medical |
Speakers' Bureau - Sirtex Medical |
Research Funding - New B Innovation (Inst); QuintilesIMS (Inst); Sirtex Medical (Inst) |